In the lead article of the Healthcare Observer, we highlight how mRNA-based therapies could show similarly impressive treatment success in other infectious diseases and in other areas such as cancer in the future.

Triumph of a new drug class

In the lead article of the Healthcare Observer, we highlight how mRNA-based therapies could show similarly impressive treatment success in other infectious diseases and in other areas such as cancer in the future.
26.05.2021 - Bellevue Asset Management